Vice President Of Development And Regulation
Jerusalem Area, Israel
Oversight and product management over the Microbiology, CMC, Toxicology, Preclinical ADME and drug PK, Regulatory & Clinical departments, guiding day-to-day operations & aligning them with company objectives. Worked closely with C-level executives and collaborated with key internal and external cross-functional key stakeholders. I provided oversight for various activities, including pre-clinical studies (PKPD), toxicology, pharmacology, microbiology, clinical advancement, and execution of regulatory affairs activities for an IND submission. I played a pivotal role in leading the company to the successful completion of a safety phase 1 clinical trial. I managed CMC aspects of drug manufacturing, focusing on ensuring API quality, scale-up, yield, and global regulatory compliance. I managed regulatory submissions to the FDA/EMA, worked closely with advisers and legal counsels, and engaged in business operations definition and management.I ensured strict compliance with regulatory guidelines under ICH guidelines, Good Clinical Practices (GCP) and clinical methodologies. I developed the product's pharmaceutical requirements for clinical usage, clinical writing (IB, IMPD, clinical study design & protocol, clinical pharmacokinetics (PK) evaluation design, endpoint definition and data analysis plan) and managed project contracts with all vendors. Moreover, I engaged in business development efforts aimed at enhancing drug development capabilities and driving strategic initiatives for the organization.